Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: RBM who wrote (2630)	6/10/1998 12:20:00 AM
From: Quad Sevens	Read Replies (2) \| Respond to of 5736

<< Despite company claims to the contrary, a 1995 market research report titled "World Clinical Lab Analytical Instrument Markets" by Frost & Sullivan estimated that the world bilirubinometer market was less than $2.5 million. >> That's from Asensio. When did CCSI estimate the size of the the world bilirubinometer market, i.e., the current world market for the measuring devices themselves? Which press release was it? My recollection is that CCSI estimated the U.S. market for bilirubin MONITORING, which is obviously something quite different. Wade

To: RBM who wrote (2630)	6/10/1998 9:32:00 AM
From: M. Frank Greiffenstein	Respond to of 5736

Mistake is not fraud... Making a mistake is not fraud. No, I do not think erroneously identifying a stock as an OTC BB stock will cause it to go down in flames. It will not cause the public float of a stock to trade hands multiple times in one trading session. Mounting disappointment in the failure of a company to make sales is a known cause of stock meltdowns. CCSI has steadily been falling since CCSIs failure to announce partners in New Orleans. Asensio's report simply adds fuel to a smoldering fire. DocStone